TRANSCEND-T2D-1 (NCT06354660), the program's first trial, reported topline results March 19, 2026, with full publication in The Lancet in June
If youre already taking antihypertensive medications, your doctor may need to watch your blood pressure closely to avoid it dropping too low
Well explain a few reasons this might happen, along with some strategies to avoid the discomfort
The dose-limited side effects for shorter-acting agents such as exenatide, lixisenatide, and liraglutide are largely gastrointestinal in nature
How do I properly dispose of used or expired BAC water vials
Przygotowanie i przechowywanie odczynnika Melanotan 2 W celu zachowania stabilnoci chemicznej oraz integralnoci struktury peptydowej naley stosowa standardowe procedury laboratoryjne waciwe dla odczynnikw biologicznych